image
MannKind Corporation MNKD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.69
-1.05 %
$ 1.43 B
Market Cap
46.9
P/E
CASH FLOW STATEMENT
42.5 M OPERATING CASH FLOW
24.69%
Growth Rates
1Year 24.69%
3Years 39.06%
5Years 19.92%
7Years 14.98%
10Years 26.39%
-96.6 M INVESTING CASH FLOW
-4761.62%
Growth Rates
1Year -4761.62%
3Years 13.92%
5Years -33.44%
7Years -31.49%
10Years -14.90%
-137 M FINANCING CASH FLOW
-100.48%
Growth Rates
1Year -100.48%
3Years -14.67%
5Years -24.28%
7Years -16.23%
10Years -11.46%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis MannKind Corporation
image
40m40m20m20m00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 27.6 M
Depreciation & Amortization 9.04 M
Capital Expenditures -9.69 M
Stock-Based Compensation 21.4 M
Change in Working Capital 0
Others -48.6 M
Free Cash Flow 32.8 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002
OPERATING CASH FLOW
Net Income 27.6 (11.9) (87.4) (80.9) (57.2) (51.9) (87.0) (117.3) 125.7 (368.4) (198.4) (191.5) (169.4) (160.8) (170.6) (220.1) (303.0) (293.2) (230.5) (114.3) (76.0) (65.9) (206.3)
Depreciation & Amortization 9.0 5.8 9.1 5.5 3.3 2.2 1.7 3.5 4.2 13.3 18.6 14.1 14.4 15.9 17.3 18.7 12.3 9.0 8.5 7.4 7.2 7.7 5.1
Deferred Income Tax 0 0 0 12.6 10.7 (4.6) 0 12.9 (79.6) 180.4 1.5 0.8 2.0 160.8 0.6 12.9 0.2 (10.6) (14.6) 0 (4.5) 0 0
Stock Based Compensation 21.4 17.6 13.4 12.2 6.5 6.2 6.9 4.8 5.1 8.7 48.6 45.2 13.3 11.2 13.6 20.2 24.8 17.6 14.7 0 4.5 0 0
Other Operating Activities (15.5) 8.0 8.2 6.6 18.4 (28.0) 5.7 3.7 5.8 67.8 10 K 2 K 6.5 (160.8) 6 K 7 K (0.2) 18.6 16.9 (1.9) 7.3 7.3 151.6
Change in Working Capital 0 14.6 (24.1) (17.7) (9.8) (12.4) 36.7 27.6 (139.3) 41.0 133.8 2.7 13.3 9.9 (9.6) (15.8) (5.3) 13.4 15.2 7.6 1.6 (1.9) 0.9
Cash From Operations 42.5 34.1 (80.7) (61.7) (28.1) (88.5) (37.7) (64.8) (78.1) (57.2) 4.1 (128.7) (119.9) (123.8) (148.7) (184.1) (271.3) (245.1) (189.8) (101.2) (59.9) (52.8) (48.7)
INVESTING CASH FLOW
Capital Expenditures (9.7) (42.4) (7.6) (11.5) (4.8) (2.6) (0.4) 0 (1.1) (10.3) (24.1) (8.0) (0.6) (6.9) (9.5) (18.9) (82.5) (78.3) (20.8) (17.2) (6.9) (5.2) (34.1)
Other Items (87.0) 40.5 12.5 (140.1) 20.0 (20.3) 0.1 16.7 17 K 82 K 0 0 77 K 3.9 (2.2) 15.8 (17.5) 116.9 (27.5) (77.2) (2.7) 9.3 (11.2)
Cash From Investing Activities (96.6) (2.0) 4.9 (151.5) 15.2 (22.8) (0.2) 16.7 (1.1) (10.2) (24.1) (8.0) (0.6) (2.9) (11.7) (3.1) (99.9) 38.7 (48.3) (94.4) (9.6) 4.1 (45.3)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 (26.9) 0 0 0 0 0 0 0 0 0 0 (1.0) 0
Total Debt Repaid (133.2) (6.9) 18 K 281.1 14.9 63.7 (5.0) 15.4 (5.0) (64.3) 60.0 4.5 12.8 53.0 182.8 135.0 30.0 0 111.3 0 0 1.4 24 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (4.1) 136.6 4.4 (12.7) 11.3 3.0 (4.2) (3.4) (2.9) 1.3 (2.3) 87.6 (0.9) (0.5) (3.4) (7.0) (0.3) (0.5) (0.3) 0 16.7 31.8 1.3
Cash From Financing Activities (137.3) 136.6 21.4 270.3 49.9 69.9 61.3 73.6 43.0 5.7 70.1 145.7 179.6 63.4 196.4 189.5 30.6 255.2 501.6 172.7 101.5 82.8 60.2
CHANGE IN CASH
Net Change In Cash (191.4) 168.7 (54.4) 57.0 36.9 (41.5) 23.3 25.5 (36.2) (61.8) 50.1 8.9 59.2 (63.4) 36.0 2.4 (340.6) 48.7 263.5 (22.9) 32.0 34.2 (33.8)
FREE CASH FLOW
Free Cash Flow 32.8 (8.3) (88.3) (73.2) (32.9) (91.0) (38.1) (64.8) (79.2) (67.5) (20.0) (136.7) (120.5) (130.7) (158.2) (202.9) (353.7) (323.4) (210.6) (118.4) (66.8) (58.0) (82.8)